The Compounding Tortoise

The Compounding Tortoise

Share this post

The Compounding Tortoise
The Compounding Tortoise
Webinar - Valuing Companies & Three Proven Metrics

Webinar - Valuing Companies & Three Proven Metrics

A nuanced and above all disciplined approach to valuing quality compounders

The Compounding Tortoise's avatar
The Compounding Tortoise
Feb 19, 2024
∙ Paid
11

Share this post

The Compounding Tortoise
The Compounding Tortoise
Webinar - Valuing Companies & Three Proven Metrics
1
Share

Hi fellow Tortoise!

Valuing companies, understanding true shareholder value creation, explaining valuation differences and building a high-quality growth portfolio: easier said than done. 

And to be fair: investing can be made simple but not easy. We don’t have to make it overly complicated, just as long as we focus on the key principles and don’t lose sight of specific elements (such as lease liabilities, right-of-use assets vs. the actual value). 

ROIC is a nuanced metric, and therefore, we should broaden our analytical toolkit with other ratios that contextualize performance and expectations.

When ROIC is a Flawed Metric - 5 Scenarios (and Examples)

The CT
·
February 11, 2024
When ROIC is a Flawed Metric - 5 Scenarios (and Examples)

Introduction Return on Invested Capital is one of the most important metrics to assess a company’s capital efficiency and effectiveness of reinvestments. Notwithstanding the obvious conclusions one can draw from ROIC (the higher the better, is it above-average, does the company have reinvestment opportunities),

Read full story

Where can we still find attractive opportunities to deploy new capital? 

Content

The table of contents for this webinar:

  • ROIC, IRR and economic profit: the trinity for compounding shareholder value

  • What’s the difference between Linde Plc and Air Products

  • The earnings bonanza is now behind us: little has changed

  • Valuing companies: presenting our common sense approach + how lease liabilities/right-of-use assets can distort ROIC, underlying free cash flow and a company’s fair value. We used Teqnion as an example

  • Portfolio strategy: what are we aiming for?

Philosophy

As a reminder:

Our stock investment portfolio is concentrated in our highest-conviction ideas (13 stocks right now). It typically takes several weeks or even months before our rigorous research process on a potential new name is fully completed.

Before we got involved in private M&A-dealmaking, our stock watchlist and portfolio consisted of 30+ names. And for us, it was impractical to follow up on each of the screened stocks in great detail. So don’t expect a continuous stream of new ideas from us.

Portfolio characteristics 

Time is the friend of a great business that can compound its invested capital at a fast clip, whilst keeping financial risks low. Here are some features of our stock investment portfolio:

  • Weighted average return on capital on organic growth: >40% (after tax)

  • Weighted average return on total invested capital (incl. M&A): 20-25% (after tax)

  • Weighted re-investment rate: >50% of NOPAT

  • Weighted dividend payout: approximately 26% of NOPAT

  • Weighted buybacks: approximately 9% of NOPAT

  • Weighted average EV/NOPAT (2024): 25x 

Based on the above, annual earnings growth is projected to come in at roughly 12% to 15%. We’ll get a 0.7% dividend yield and 0.35% buyback yield. That’s 13% to 16% total IRR, before any assumption on declining or rising valuation multiples after taking a position. It’s far better to benchmark your fundamental portfolio characteristics than its (short-term) stock performance.

Webinar and material

You can watch the webinar through the below inserted video. The presentation material can be downloaded via PDF.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 The Compounding Tortoise
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share